Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Key Sessions

Professor Kenneth Getz

Examining the growing role of CROs as facilitators in the convergence of clinical research and clinical care

CSDD, Tufts University School of Medicine, USA

Neal McCarthy

Business and Financial analysis and impact of mergers and acquisition of the CRO’s on the Pharma Industry

Fairmount Partners, USA

Inma Martinez

The future of Healthcare- Mobile Health, Digital, AI and Innovation with regards to clinical trials and healthcare- relate to other industries

Deep Science Ventures, UK

Nov 27
Show Filter
12:30 - 14:00 90 mins
Registration and Morning Coffee
14:00 - 14:10 10 mins
OPENING PLENARY
Opening remarks from the Chairperson
14:10 - 14:55 45 mins
OPENING PLENARY
Examining the growing role of CROs as facilitators in the convergence of clinical research and clinical care
  • Professor Kenneth Getz - Director and Associate Professor, CSDD, Tufts University School of Medicine, USA
more

The level of inefficiency associated with finding and engaging investigative sites and study volunteers combined with the growing value of rich data and analytics are driving the convergence of clinical research into large clinical care settings. Recent transactions indicate that leading CROs are anticipating this convergence and leveraging new approaches to differentiate their service offerings.  This session characterizes the operating conditions leading to the eventual convergence of clinical research and clinical care environments, discusses the critical role of CROs as facilitators of this convergence, and provides insight into a new and disruptive clinical trial paradigm punctuated by flexibility, customization and integration.

14:55 - 15:40 45 mins
OPENING PLENARY
Business and Financial analysis and impact of mergers and acquisition of the CRO’s on the Pharma Industry
  • Neal McCarthy - Managing Director, Fairmount Partners, USA
more
  • Building a better CRO – services, geography and therapeutic expertise
  • CRO Models - One stop shop to FSP to staffing
  • More pharma than pharma
  • Unique merger models – tea and biscuits or chalk and cheese
  • Private Equity driving CROs mergers
  • The Billion 7, the Second Line, the Asia Pack, the Early Birds and Non-CROs
  • The good and bad of larger versus specialist/regional CROs
  • Bolt-ons versus merger of equals
  • What to do when your CRO gets gobbled
  • Merger cycles and new growth
  • Evolution – what just happened, and what will happen soon
  • Long term prognosis and the likely effects of research sites mergers and virtual trials 
15:40 - 16:25 45 mins
OPENING PLENARY
The future of Healthcare- Mobile Health, Digital, AI and Innovation with regards to clinical trials and healthcare- relate to other industries
  • Inma Martinez - Venture Partner, Data Sciences & Product Innovation, Deep Science Ventures, UK
more
16:25 - 17:30 65 mins
OPENING PLENARY
PANEL: The Future of Clinical Trials - New partnerships, new innovations and new processes
  • Moderator: Professor Kenneth Getz - Director and Associate Professor, CSDD, Tufts University School of Medicine, USA
  • E.B. McLindon - Senior Vice President, Site & Patient Recruitment, ICON plc
more
  • News flash over the 12 months: significant changes and news from the panel’s perspective
  • Overview of compelling new mergers and acquisition, partnerships and collaborations
  • Greatest challenges anticipated as we move closer to this new future vision
  • The role of new technologies in supporting this new future vision
17:30 - 19:00 90 mins
Drinks Reception